Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya ® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM
Condition: Multiple Sclerosis, Relapsing-Remitting Interventions: Other: NeuroQuant; Other: Automated Neuropsychological Assessment Matrices; Other: EDSS; Other: Physical Examination Sponsor: George Washington University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2023 Category: Research Source Type: clinical trials